Author

Mark A. Strivens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:gene regulatory network inference· 2 Assay:GWAS summary statistics· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Sayoni DasiD· 3 shared Steve GardneriD· 2 shared A Malinowski· 1 shared Alpha Tom KodamulliliD· 1 shared Andrea ZalianiiD· 1 shared Bruce T. SchultziD· 1 shared Carsten ClausseniD· 1 shared Christian EbelingiD· 1 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Sayoni DasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicineArtificial Intelligence in the Life SciencesPeer-reviewedJan 31, 2025

Actively Protective Combinatorial Analysis: a Scalable Novel Method for Detecting Variants that Contribute to Reduced Disease Prevalence in High-Risk Individuals

Jason M. Sardell, Sayoni Das, K Taylor…·Steve Gardner

This paper introduces a method to detect genetic variants that reduce disease risk in high-risk individuals, identifying protective signatures that could inform drug targets and precision medicine.

5 citations

humanGWAS summary statistics

BioinformaticsbioRxivPreprintSep 23, 2020

The COVID-19 PHARMACOME: A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization

Bruce T. Schultz, Andrea Zaliani, Christian Ebeling…·Martin Hofmann‐Apitius

The paper presents a drug-target-mechanism graph to identify synergistic drug combinations for SARS-CoV-2 treatment, validated through experimental testing.

2 citations

humanstatistical model

Genetic & Genomic MedicinemedRxivPreprintJun 17, 2020

Analysis of Genetic Host Response Risk Factors in Severe COVID-19 Patients

Krystyna Taylor, Sayoni Das, Matthew W Pearson…·Steve Gardner

This study identifies 68 genetic risk factors associated with severe COVID-19 using combinatorial analysis, highlighting pathways like calcium signaling and potential drug targets.

20 citations

humanGWAS summary statistics